Providers
All 15 in CA
ACCENTCARE HOME HEALTH OF CALIFORNIA, INC.
NPI 1386054989, organization, El Centro, CA, Hospice Care, Community Based
Evidence tier
No indicators
No detector reached this NPI and it appears on none of the loaded lists.
Provider networks
D1-00205 ranked 205161 providers around Sugar Land, TX: 57 hospices, 102 home health agencies, 2 nursing facilities.
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | ACCENTCARE HOME HEALTH OF CALIFORNIA, INC. (also ACHH OF CA - EL CENTRO HOSPICE) |
| Type | Organization |
| Status | Active |
| NPI issued | May 5, 2014, last updated October 18, 2021 |
| Practice location | 2344 S 2ND ST STE B, El Centro, CA 92243-5606, 760-675-3014 |
| Mailing address | 17855 DALLAS PKWY STE 200, Dallas, TX 75287-6857 |
| Authorized official | M'LISS KANE (VP Legal) |
| Specialties | Hospice Care, Community Based (251G00000X, primary) |
In this area
15 providers in Imperial County, CA carry an indicator in the public record, with $21.1M at stake between them. The most common is more hours than a day holds, on 11 of them, followed by part of a provider network on 3. 1 is tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | JAVAD AGHALOO EL Centro, CA, ranked 233 | $23K |
|
| 3 | ARIA HOSPICE LLC EL Centro, CA, ranked 1163 | $458K |
|
| 3 | ASSISTING HANDS HEALTH CARE EL Centro, CA, ranked 1768 | $0 |
|
| 3 | IMPERIAL CARE LLC EL Centro, CA, ranked 3534 | $0 |
|
| 4 | AMEEN ALSHAREEF EL Centro, CA, ranked 7494 | $4.0M |
|
| 4 | VISHWA KAPOOR EL Centro, CA, ranked 7604 | $2.6M |
|
| 4 | HAMID ZADEH Imperial, CA, ranked 7825 | $1.1M |
|
| 4 | BRIAN TYSON EL Centro, CA, ranked 8360 | $6.3M |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.